The University of Southampton
University of Southampton Institutional Repository

BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib

BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib
BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib

Patients with chronic lymphocytic leukemia (CLL) progressing on ibrutinib constitute an unmet need. Though Bruton tyrosine kinase (BTK) and PLCG2 mutations are associated with ibrutinib resistance, their frequency and relevance to progression are not fully understood. In this multicenter retrospective observational study, we analyzed 98 patients with CLL on ibrutinib (49 relapsing after an initial response and 49 still responding after ≥1 year of continuous treatment) using a next-generation sequencing (NGS) panel (1% sensitivity) comprising 13 CLL-relevant genes including BTK and PLCG2. BTK hotspot mutations were validated by droplet digital polymerase chain reaction (ddPCR) (0.1% sensitivity). By integrating NGS and ddPCR results, 32 of 49 relapsing cases (65%) carried at least 1 hotspot BTK and/or PLCG2 mutation(s); in 6 of 32, BTK mutations were only detected by ddPCR (variant allele frequency [VAF] 0.1% to 1.2%). BTK/PLCG2 mutations were also identified in 6 of 49 responding patients (12%; 5/6 VAF <10%), of whom 2 progressed later. Among the relapsing patients, the BTK-mutated (BTK mut) group was enriched for EGR2 mutations, whereas BTK-wildtype (BTK wt) cases more frequently displayed BIRC3 and NFKBIE mutations. Using an extended capture-based panel, only BRAF and IKZF3 mutations showed a predominance in relapsing cases, who were enriched for del(8p) (n = 11; 3 BTK wt). Finally, no difference in TP53 mutation burden was observed between BTK mut and BTK wt relapsing cases, and ibrutinib treatment did not favor selection of TP53-aberrant clones. In conclusion, we show that BTK/PLCG2 mutations were absent in a substantial fraction (35%) of a real-world cohort failing ibrutinib, and propose additional mechanisms contributing to resistance.

2473-9529
2794-2806
Bonfiglio, Silvia
5478c49a-017d-4678-82dd-f0c2425e0605
Sutton, Lesley-Ann
cb563f52-9629-4fe0-bebf-cf13e4480b88
Ljungstrom, Viktor
c755a09c-c2c8-4460-911b-9717dcc02d6d
Capasso, Antonella
b0f237ac-1479-40cb-82c3-e1bef760948b
Pandzic, Tatjana
f972ee61-bcf9-448f-a642-a488fb41c470
Westrom, Simone
cae7e1ea-ab47-4042-87e4-0874b5f6e61d
Foroughi-Asl, Hassan
747f94ee-05cc-4fc2-8925-fecac350622c
Skaftason, Aron
a162505b-de85-4079-ac38-39f9d215a8ad
Gellerbring, Anna
74596474-8b2e-4a11-947f-dbfa82f5a642
Lyander, Anna
e2df9b46-1f49-4f4c-aab3-d45da7676571
Gandini, Francesca
ed80c5c3-fdfb-492f-886c-d0b2e2614355
Gaidano, Gianluca
1a6a7107-107b-4891-82e0-5fedadd2f65a
Trentin, Livio
457595df-2d40-4392-931c-3919eb5620ec
Bonello, Lisa
1da7e2c9-a604-423a-90cb-af8c7fd8ca39
Reda, Gianluigi
bea848f6-ab46-41d1-9c56-913ac6ee5923
Bödör, Csaba
2a74ce7f-a7ae-4759-b466-eeb128d942e2
Stavroyianni, Niki
af659f48-f9c7-4bbc-9c50-1b1480c7842c
Tam, Constantine
29399e89-1999-4a9d-af9d-61f5abd86fba
Marasca, Roberto
918148d0-8f99-4a29-8322-1b34f6d7dd00
Forconi, Francesco
ce9ed873-58cf-4876-bf3a-9ba1d163edc8
Panayiotidis, Panayiotis
0afa64c3-2271-4e58-9ba5-39e72785dba0
Ringshausen, Igno
169e0471-409a-403d-92ef-ab7699a95da3
Jaksic, Ozren
d7ebbd2a-79a4-4d63-bdb6-836102d8f44d
Frustaci, Anna Maria
734c75ce-c0fb-4c75-a065-97920c236b08
Iyengar, Sunil
1c3f5958-2c92-4dab-ae63-fdd3dadaaf25
Coscia, Marta
7ae299af-adc7-41fd-aa4b-b3ee6fe91d83
Mulligan, Stephen
6e1dca7a-13af-4102-9608-bcd7bee2f4be
Ysebaert, Loic
92f73817-4646-483a-9f90-068fc243252b
Strugov, Vladimir
34ddc43a-2389-4f91-a35c-fa5219da5ad8
Pavlovsky, Carolina
64fb4db6-8c18-4892-bcee-c39e14f6ac01
Walewska, Renata
326c1001-fcdb-452a-aa53-2c82a1ca39a5
Osterborg, Anders
5e4f7c9d-d019-47af-8d78-d54f14a4394c
Cortese, Diego
03e993e4-bba2-4422-91cf-b3d39261d203
Ranghetti, Pamela
ad9b2031-df56-4348-8887-cd2a50dcdd5b
Baliakas, Panagiotis
b091c9ed-a378-4659-862f-bb725a5a563a
Stamatopoulos, Kostas
04185c9f-28ac-4693-bcff-4b6f2081de5c
Scarfo, Lydia
f3cd0dc6-1e11-4771-b8a1-bff627b90811
Rosenquist, Richard
6a175d34-f0e0-4291-ab9f-9a12517e5165
Ghia, Paolo
f990dd0a-e34d-47ab-9084-300724bbebe4
Bonfiglio, Silvia
5478c49a-017d-4678-82dd-f0c2425e0605
Sutton, Lesley-Ann
cb563f52-9629-4fe0-bebf-cf13e4480b88
Ljungstrom, Viktor
c755a09c-c2c8-4460-911b-9717dcc02d6d
Capasso, Antonella
b0f237ac-1479-40cb-82c3-e1bef760948b
Pandzic, Tatjana
f972ee61-bcf9-448f-a642-a488fb41c470
Westrom, Simone
cae7e1ea-ab47-4042-87e4-0874b5f6e61d
Foroughi-Asl, Hassan
747f94ee-05cc-4fc2-8925-fecac350622c
Skaftason, Aron
a162505b-de85-4079-ac38-39f9d215a8ad
Gellerbring, Anna
74596474-8b2e-4a11-947f-dbfa82f5a642
Lyander, Anna
e2df9b46-1f49-4f4c-aab3-d45da7676571
Gandini, Francesca
ed80c5c3-fdfb-492f-886c-d0b2e2614355
Gaidano, Gianluca
1a6a7107-107b-4891-82e0-5fedadd2f65a
Trentin, Livio
457595df-2d40-4392-931c-3919eb5620ec
Bonello, Lisa
1da7e2c9-a604-423a-90cb-af8c7fd8ca39
Reda, Gianluigi
bea848f6-ab46-41d1-9c56-913ac6ee5923
Bödör, Csaba
2a74ce7f-a7ae-4759-b466-eeb128d942e2
Stavroyianni, Niki
af659f48-f9c7-4bbc-9c50-1b1480c7842c
Tam, Constantine
29399e89-1999-4a9d-af9d-61f5abd86fba
Marasca, Roberto
918148d0-8f99-4a29-8322-1b34f6d7dd00
Forconi, Francesco
ce9ed873-58cf-4876-bf3a-9ba1d163edc8
Panayiotidis, Panayiotis
0afa64c3-2271-4e58-9ba5-39e72785dba0
Ringshausen, Igno
169e0471-409a-403d-92ef-ab7699a95da3
Jaksic, Ozren
d7ebbd2a-79a4-4d63-bdb6-836102d8f44d
Frustaci, Anna Maria
734c75ce-c0fb-4c75-a065-97920c236b08
Iyengar, Sunil
1c3f5958-2c92-4dab-ae63-fdd3dadaaf25
Coscia, Marta
7ae299af-adc7-41fd-aa4b-b3ee6fe91d83
Mulligan, Stephen
6e1dca7a-13af-4102-9608-bcd7bee2f4be
Ysebaert, Loic
92f73817-4646-483a-9f90-068fc243252b
Strugov, Vladimir
34ddc43a-2389-4f91-a35c-fa5219da5ad8
Pavlovsky, Carolina
64fb4db6-8c18-4892-bcee-c39e14f6ac01
Walewska, Renata
326c1001-fcdb-452a-aa53-2c82a1ca39a5
Osterborg, Anders
5e4f7c9d-d019-47af-8d78-d54f14a4394c
Cortese, Diego
03e993e4-bba2-4422-91cf-b3d39261d203
Ranghetti, Pamela
ad9b2031-df56-4348-8887-cd2a50dcdd5b
Baliakas, Panagiotis
b091c9ed-a378-4659-862f-bb725a5a563a
Stamatopoulos, Kostas
04185c9f-28ac-4693-bcff-4b6f2081de5c
Scarfo, Lydia
f3cd0dc6-1e11-4771-b8a1-bff627b90811
Rosenquist, Richard
6a175d34-f0e0-4291-ab9f-9a12517e5165
Ghia, Paolo
f990dd0a-e34d-47ab-9084-300724bbebe4

Bonfiglio, Silvia, Sutton, Lesley-Ann, Ljungstrom, Viktor, Capasso, Antonella, Pandzic, Tatjana, Westrom, Simone, Foroughi-Asl, Hassan, Skaftason, Aron, Gellerbring, Anna, Lyander, Anna, Gandini, Francesca, Gaidano, Gianluca, Trentin, Livio, Bonello, Lisa, Reda, Gianluigi, Bödör, Csaba, Stavroyianni, Niki, Tam, Constantine, Marasca, Roberto, Forconi, Francesco, Panayiotidis, Panayiotis, Ringshausen, Igno, Jaksic, Ozren, Frustaci, Anna Maria, Iyengar, Sunil, Coscia, Marta, Mulligan, Stephen, Ysebaert, Loic, Strugov, Vladimir, Pavlovsky, Carolina, Walewska, Renata, Osterborg, Anders, Cortese, Diego, Ranghetti, Pamela, Baliakas, Panagiotis, Stamatopoulos, Kostas, Scarfo, Lydia, Rosenquist, Richard and Ghia, Paolo (2023) BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib. Blood Advances, 7 (12), 2794-2806. (doi:10.1182/bloodadvances.2022008821).

Record type: Article

Abstract

Patients with chronic lymphocytic leukemia (CLL) progressing on ibrutinib constitute an unmet need. Though Bruton tyrosine kinase (BTK) and PLCG2 mutations are associated with ibrutinib resistance, their frequency and relevance to progression are not fully understood. In this multicenter retrospective observational study, we analyzed 98 patients with CLL on ibrutinib (49 relapsing after an initial response and 49 still responding after ≥1 year of continuous treatment) using a next-generation sequencing (NGS) panel (1% sensitivity) comprising 13 CLL-relevant genes including BTK and PLCG2. BTK hotspot mutations were validated by droplet digital polymerase chain reaction (ddPCR) (0.1% sensitivity). By integrating NGS and ddPCR results, 32 of 49 relapsing cases (65%) carried at least 1 hotspot BTK and/or PLCG2 mutation(s); in 6 of 32, BTK mutations were only detected by ddPCR (variant allele frequency [VAF] 0.1% to 1.2%). BTK/PLCG2 mutations were also identified in 6 of 49 responding patients (12%; 5/6 VAF <10%), of whom 2 progressed later. Among the relapsing patients, the BTK-mutated (BTK mut) group was enriched for EGR2 mutations, whereas BTK-wildtype (BTK wt) cases more frequently displayed BIRC3 and NFKBIE mutations. Using an extended capture-based panel, only BRAF and IKZF3 mutations showed a predominance in relapsing cases, who were enriched for del(8p) (n = 11; 3 BTK wt). Finally, no difference in TP53 mutation burden was observed between BTK mut and BTK wt relapsing cases, and ibrutinib treatment did not favor selection of TP53-aberrant clones. In conclusion, we show that BTK/PLCG2 mutations were absent in a substantial fraction (35%) of a real-world cohort failing ibrutinib, and propose additional mechanisms contributing to resistance.

Text
Blood_Advances_BTK_PLCG2_mutation_resubmitted - Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
bloodadvances.2022008821 - Version of Record
Available under License Other.
Download (1MB)

More information

Accepted/In Press date: 2 January 2023
e-pub ahead of print date: 25 January 2023
Published date: 27 June 2023
Additional Information: © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Identifiers

Local EPrints ID: 475963
URI: http://eprints.soton.ac.uk/id/eprint/475963
ISSN: 2473-9529
PURE UUID: 7eca68c1-8aa0-4800-9cc2-5b096a7fa243
ORCID for Francesco Forconi: ORCID iD orcid.org/0000-0002-2211-1831

Catalogue record

Date deposited: 03 Apr 2023 16:34
Last modified: 17 Mar 2024 03:27

Export record

Altmetrics

Contributors

Author: Silvia Bonfiglio
Author: Lesley-Ann Sutton
Author: Viktor Ljungstrom
Author: Antonella Capasso
Author: Tatjana Pandzic
Author: Simone Westrom
Author: Hassan Foroughi-Asl
Author: Aron Skaftason
Author: Anna Gellerbring
Author: Anna Lyander
Author: Francesca Gandini
Author: Gianluca Gaidano
Author: Livio Trentin
Author: Lisa Bonello
Author: Gianluigi Reda
Author: Csaba Bödör
Author: Niki Stavroyianni
Author: Constantine Tam
Author: Roberto Marasca
Author: Panayiotis Panayiotidis
Author: Igno Ringshausen
Author: Ozren Jaksic
Author: Anna Maria Frustaci
Author: Sunil Iyengar
Author: Marta Coscia
Author: Stephen Mulligan
Author: Loic Ysebaert
Author: Vladimir Strugov
Author: Carolina Pavlovsky
Author: Renata Walewska
Author: Anders Osterborg
Author: Diego Cortese
Author: Pamela Ranghetti
Author: Panagiotis Baliakas
Author: Kostas Stamatopoulos
Author: Lydia Scarfo
Author: Richard Rosenquist
Author: Paolo Ghia

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×